France’s Valneva says trial vaccine for chikungunya post 98.9% rate
HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.
HQ Team June 10, 2023: A study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), found that using the oral.
HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.
HQ Team June 9, 2023: Metformin, a cheap and widely-used diabetes drug, reduces the incidence of long Covid by nearly 40 per cent.
HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.
HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.
HQ Team June 8, 2023: The European Union has announced a 1.23 billion euro initiative to prevent mental health issues and find affordable.
HQ Team June 7, 2023: A team of researchers at George Washington University has developed an ingestible pill camera that can be “driven”.
HQ Team June 7, 2023: Vitamins supplements have become a routine part of our health regime and since these pills are not as.
HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for.